June 18, 2010
Kaneka Buys Belgium Biologics Maker
Kaneka Co., a chemical-oriented conglomerite, announced that it has spent 4 billion yen to acquire a majority stake of Eurogentec SA, a Belgian manufacturer of proteins, ligonucleotides and other biologics. Kaneka has a contracted pharmaceuticals manufacturer. It has been developing R&D to produce biopharmaceutical ingredients. Through acquiring Eurogenetic, Kaneka intends to jump-start the business.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment